InvestorsHub Logo
Followers 221
Posts 748
Boards Moderated 1
Alias Born 12/10/2013

Re: None

Sunday, 05/04/2014 9:52:08 PM

Sunday, May 04, 2014 9:52:08 PM

Post# of 40501
My take on it. Come follow my board for weekly stock scans. New ones just posted. http://investorshub.advfn.com/Illuminati-28233/

$INO

DD Notes ~ http://www.ddnotesmaker.com/INO

##### recent news/filings ~ source: finance.yahoo.com

Mon, 21 Apr 2014 14:35:00 GMT ~ Inovio Pharmaceuticals (INO) Is Today's Dead Cat Bounce Stock
read full: http://www.thestreet.com/story/12675964/1/inovio-pharmaceuticals-ino-is-todays-dead-cat-bounce-stock.html?puc=yahoo&cm_ven=YAHOO
*********************************************************

Wed, 09 Apr 2014 16:06:20 GMT ~ I Hear The Shorts Knocking, But, I'm Staying Long On Inovio
read full: http://seekingalpha.com/article/2133403-i-hear-the-shorts-knocking-but-im-staying-long-on-inovio?source=yahoo
*********************************************************

Mon, 07 Apr 2014 13:30:00 GMT ~ 3 Stocks To Profit From The Cutting-Edge Vaccine Market
read full: http://finance.yahoo.com/news/biotech-market-could-quadruple-3-133000076.html
*********************************************************

Fri, 04 Apr 2014 15:50:00 GMT ~ Use Options For A Chance To Buy INO At A 42% Discount
read full: http://www.thestreet.com/story/12626953/1/use-options-for-a-chance-to-buy-ino-at-a-42-discount.html?puc=yahoo&cm_ven=YAHOO
*********************************************************

Tue, 01 Apr 2014 08:00:00 GMT ~ Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
[PR Newswire] - BLUE BELL, Pa., April 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He will report to Inovio's Chief Operating Officer Dr. Niranjan Sardesai. Prior to joining Inovio, Mr. Brandreth had a successful career transitioning start-up clinical biotech operations into successful commercial entities;
read full: http://finance.yahoo.com/news/inovio-pharmaceuticals-continues-building-senior-080000621.html
*********************************************************

##### chart ~ source: stockcharts.com



##### chart ~ source: eoddata.com



##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/INO/company-info
Ticker: $INO
OTC Market Place: Not Available
CIK code: 0001055726
Company name: Inovio Pharmaceuticals, Inc.
Company website: http://www.inovio.com/
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001055726&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/INO/filings
Latest financials: http://www.otcmarkets.com/stock/INO/financials
Latest news: http://www.otcmarkets.com/stock/INO/news - http://finance.yahoo.com/q/h?s=INO+Headlines

Major holdings: http://data.cnbc.com/quotes/INO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=INO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/INO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=INO

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=INO&search=search

DTCC: http://search2.dtcc.com/?q=Inovio+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Inovio+Pharmaceuticals%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Inovio+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.inovio.com/
Alexa: http://www.alexa.com/siteinfo/http://www.inovio.com/#
Corporate website internet archive: http://web.archive.org/web/*/http://www.inovio.com/

Short Sales: http://www.otcmarkets.com/stock/INO/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/INO/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/INO/research
Historical Prices: http://finance.yahoo.com/q/hp?s=INO+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=INO+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=INO+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=INO+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=INO+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=INO+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=INO
Balance Sheet: http://finance.yahoo.com/q/bs?s=INO
Cash Flow: http://finance.yahoo.com/q/cf?s=INO+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/INO
Bloomberg: http://www.bloomberg.com/quote/INO:US
Morningstar: http://quotes.morningstar.com/stock/s?t=INO
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=INO
Barchart: http://www.barchart.com/quotes/stocks/INO
OTC Short Report: http://otcshortreport.com/index.php?index=INO
Investopedia: http://www.investopedia.com/markets/stocks/INO/?wa=0

http://www.pennystocktweets.com/stocks/profile/INO

##### last known share structure ~ source: otcmarkets.com

Market Value: $613,400,986 a/o May 02, 2014
Shares Outstanding: 239,609,760 a/o Mar 07, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com

The achievements of stimulating the immune system through vaccination have been profound. INO?s synthetic vaccines are designed to treat as well as prevent illnesses, aiming to break the body?s tolerance of cancerous cells and protect against diverse while changing strains of infectious diseases. INO?s SynCon? vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile.Less >>

DD Notes ~ http://www.ddnotesmaker.com/INO


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News